Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema
2013; Wiley; Volume: 76; Issue: 6 Linguagem: Inglês
10.1111/bcp.12132
ISSN1365-2125
AutoresColm Farrell, Siobhán Hayes, Anurag Relan, Edwin S. van Amersfoort, Rienk Pijpstra, C. Erik Hack,
Tópico(s)Hemophilia Treatment and Research
ResumoTo characterize the pharmacokinetics (PK) of recombinant human C1 inhibitor (rhC1INH) in healthy volunteers and hereditary angioedema (HAE) patients.
Referência(s)